Matteo Bauckneht

Ospedale Policlinico San Martino

Papers

1

Total Citations

1

H-Index

1

About

Dr. Matteo Bauckneht is a leading figure in nuclear medicine and oncological imaging, with a primary research focus on prostate cancer diagnostics and theranostics. His work centers on advancing the clinical application of prostate-specific membrane antigen (PSMA)-PET imaging, a critical tool for cancer staging and treatment planning. Dr. Bauckneht’s major contributions include pioneering studies that evaluate how specialists—particularly urologists—interpret PSMA-PET scans, addressing a significant gap in interdisciplinary communication and diagnostic accuracy. His most cited work, a prospective multicentric evaluation published in 2025, has already garnered attention for its practical insights into improving scan interpretation among non-radiologists. Beyond this, his research portfolio explores the integration of molecular imaging with therapeutic strategies, enhancing personalized medicine for prostate cancer patients. With a growing citation impact, Dr. Bauckneht’s studies are shaping clinical guidelines and fostering collaboration between urologists and nuclear medicine experts. His achievements underscore a commitment to bridging technical imaging expertise with frontline clinical decision-making, making him a pivotal voice in the evolution of precision oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Interpretation of PSMA-PET Among Urologists: A Prospective Multicentric Evaluation
1 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: Ospedale Policlinico San Martino

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago